Annual Accounts Receivable
$10.92 B
-$236.00 M-2.12%
December 1, 2024
Summary
- As of March 9, 2025, ABBV annual accounts receivable is $10.92 billion, with the most recent change of -$236.00 million (-2.12%) on December 1, 2024.
- During the last 3 years, ABBV annual accounts receivable has risen by +$942.00 million (+9.44%).
- ABBV annual accounts receivable is now -2.98% below its all-time high of $11.25 billion, reached on December 31, 2022.
Performance
ABBV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$10.92 B
-$553.00 M-4.82%
December 1, 2024
Summary
- As of March 9, 2025, ABBV quarterly accounts receivable is $10.92 billion, with the most recent change of -$553.00 million (-4.82%) on December 1, 2024.
- Over the past year, ABBV quarterly accounts receivable has stayed the same.
- ABBV quarterly accounts receivable is now -8.62% below its all-time high of $11.95 billion, reached on March 31, 2024.
Performance
ABBV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ABBV Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.1% | 0.0% |
| 3 y3 years | +9.4% | -2.8% |
| 5 y5 years | +101.2% | +101.2% |
ABBV Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.0% | +9.4% | -8.6% | +9.4% |
| 5 y | 5-year | -3.0% | +101.2% | -8.6% | +101.2% |
| alltime | all time | -3.0% | +223.7% | -8.6% | +264.7% |
AbbVie Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $10.92 B(-2.1%) | $10.92 B(-4.8%) |
| Sep 2024 | - | $11.47 B(-2.1%) |
| Jun 2024 | - | $11.72 B(-1.9%) |
| Mar 2024 | - | $11.95 B(+7.1%) |
| Dec 2023 | $11.15 B(-0.9%) | $11.15 B(-2.3%) |
| Sep 2023 | - | $11.41 B(-0.7%) |
| Jun 2023 | - | $11.49 B(+0.2%) |
| Mar 2023 | - | $11.47 B(+1.9%) |
| Dec 2022 | $11.25 B(+12.8%) | $11.25 B(+4.8%) |
| Sep 2022 | - | $10.74 B(-4.4%) |
| Jun 2022 | - | $11.24 B(+4.7%) |
| Mar 2022 | - | $10.73 B(+7.6%) |
| Dec 2021 | $9.98 B(+13.1%) | $9.98 B(+7.5%) |
| Sep 2021 | - | $9.28 B(-6.4%) |
| Jun 2021 | - | $9.91 B(+3.4%) |
| Mar 2021 | - | $9.59 B(+8.7%) |
| Dec 2020 | $8.82 B(+62.5%) | $8.82 B(+4.8%) |
| Sep 2020 | - | $8.42 B(+0.7%) |
| Jun 2020 | - | $8.35 B(+31.3%) |
| Mar 2020 | - | $6.36 B(+17.2%) |
| Dec 2019 | $5.43 B(+0.8%) | $5.43 B(-1.8%) |
| Sep 2019 | - | $5.53 B(+0.9%) |
| Jun 2019 | - | $5.48 B(-3.5%) |
| Mar 2019 | - | $5.68 B(+5.5%) |
| Dec 2018 | $5.38 B | $5.38 B(-6.9%) |
| Sep 2018 | - | $5.78 B(-0.2%) |
| Jun 2018 | - | $5.79 B(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $5.84 B(+14.8%) |
| Dec 2017 | $5.09 B(+6.9%) | $5.09 B(+4.0%) |
| Sep 2017 | - | $4.89 B(+0.7%) |
| Jun 2017 | - | $4.86 B(+3.9%) |
| Mar 2017 | - | $4.68 B(-1.7%) |
| Dec 2016 | $4.76 B(+0.6%) | $4.76 B(-4.8%) |
| Sep 2016 | - | $5.00 B(-1.0%) |
| Jun 2016 | - | $5.05 B(+6.2%) |
| Mar 2016 | - | $4.75 B(+0.5%) |
| Dec 2015 | $4.73 B(+26.6%) | $4.73 B(+3.4%) |
| Sep 2015 | - | $4.57 B(+4.7%) |
| Jun 2015 | - | $4.37 B(+3.6%) |
| Mar 2015 | - | $4.21 B(+12.8%) |
| Dec 2014 | $3.73 B(-3.1%) | $3.73 B(+4.0%) |
| Sep 2014 | - | $3.59 B(-2.5%) |
| Jun 2014 | - | $3.68 B(+0.9%) |
| Mar 2014 | - | $3.65 B(-5.3%) |
| Dec 2013 | $3.85 B(-10.3%) | $3.85 B(+1.5%) |
| Sep 2013 | - | $3.80 B(+1.1%) |
| Jun 2013 | - | $3.75 B(-12.7%) |
| Mar 2013 | - | $4.30 B(+0.0%) |
| Dec 2012 | $4.30 B(+12.6%) | $4.30 B(+38.8%) |
| Sep 2012 | - | $3.10 B(+3.5%) |
| Jun 2012 | - | $2.99 B(-17.9%) |
| Mar 2012 | - | $3.65 B(-4.5%) |
| Dec 2011 | $3.82 B(+13.2%) | $3.82 B |
| Dec 2010 | $3.37 B | - |
FAQ
- What is AbbVie annual accounts receivable?
- What is the all time high annual accounts receivable for AbbVie?
- What is AbbVie annual accounts receivable year-on-year change?
- What is AbbVie quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AbbVie?
- What is AbbVie quarterly accounts receivable year-on-year change?
What is AbbVie annual accounts receivable?
The current annual accounts receivable of ABBV is $10.92 B
What is the all time high annual accounts receivable for AbbVie?
AbbVie all-time high annual accounts receivable is $11.25 B
What is AbbVie annual accounts receivable year-on-year change?
Over the past year, ABBV annual accounts receivable has changed by -$236.00 M (-2.12%)
What is AbbVie quarterly accounts receivable?
The current quarterly accounts receivable of ABBV is $10.92 B
What is the all time high quarterly accounts receivable for AbbVie?
AbbVie all-time high quarterly accounts receivable is $11.95 B
What is AbbVie quarterly accounts receivable year-on-year change?
Over the past year, ABBV quarterly accounts receivable has changed by $0.00 (0.00%)